IBIsobel Braithwaite

Isobel Braithwaite

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Isobel Braithwaite has a total of 100 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Adapting the MPOWER policy framework for fossil fuels and public health: reflections on content and process

    by T Keller, I Braithwaite, A Brook, J Beagley, S Narayan, Ta Deivanayagam

    We argue in the paper that there is much to learn from previous public health advocacy and action against health-harming industries, such as tobacco, through a ‘Commercial Determinants of Health’ (CDoH) lens. The MPOWER framework is an example of work in tobacco control field which has been a valuable and cross-cutting framework used to guide and support tobacco policy implementation and prioritisation since its development in 2008, contributing to progress in reducing smoking rates and associated morbidity and mortality.


  • Open Access

    ‘Best practice’ for healthy urban development: learning from others while maintaining local responsiveness in an emerging planning specialism

    by Helen Pineo, Gemma Moore, Karla Barrantes Chaves, Elizabeth Cooper, Vafa Dianati, Isobel Braithwaite


  • Open Access

    Barriers in accessing healthcare during the COVID-19 pandemic: analysis of the Virus Watch community cohort study

    by Dee Menezes, Chloe Siegele-Brown, Alexei Yavlinsky, Vincent Nguyen, Isobel Braithwaite, Rachel Burns, Sam Tweed, Youssof Oskrochi, Jana Kovar, Wing Lam Erica Fong, et al.

    Background Differential barriers to accessing healthcare contribute to inequitable health outcomes. This study aims to describe the characteristics of individuals who experienced barriers, and what those barriers were, during the COVID-19 pandemic. Methods We analysed data from Virus Watch: an online survey-based community study of households in England and Wales. The primary outcome was reported difficulty accessing healthcare in the previous year. Results Minority ethnic participants reported difficulty accessing healthcare more than White British participants (41.6% vs 37%), while for migrants this was at broadly similar levels to non-migrants. Those living in the most deprived areas reported difficulty more than those living in the least deprived quintile (45.5% vs. 35.5%). The most frequently reported barrier was cancellation/disruption of services due to the COVID-19 pandemic (72.0%) followed by problems with digital or telephone access (21.8%). Ethnic minority participants, migrants, and those from deprived areas more commonly described “insufficient flexibility of appointments” and “not enough time to explain complex needs” as barriers. Conclusions Minority ethnic individuals and those living in deprived areas were more likely to experience barriers to healthcare during the COVID-19 pandemic, and it is essential they are addressed as services seek to manage backlogs of care.

  • Open Access

    Examining the association of live virus neutralisation activity of capillary microsamples and risk of SARS-CoV-2 infections: a nested case control study within the Virus Watch community cohort

    by Alexei Yavlinsky, Vincent G. Nguyen, Sarah Beale, Emma Wall, Mary Y Wu, Isobel Braithwaite, Jana Kovar, Madhumita Shrotri, Annalan M D Navaratnam, Wing Lam Erica Fong, et al.

    Due to the proliferation of new SARS-CoV-2 variants, most COVID-19 cases are now caused by post-vaccine infections and a substantial proportion are reinfections. While prior research on correlates of protection has focused on the role of anti-spike antibodies, the results of the corresponding antibody assays may not accurately predict the risk of infection with new SARS-CoV-2 variants. In this study, we investigated the association between live virus neutralising antibody activity and SARS-CoV-2 infection risk using self-administered capillary microsample blood tests from VirusWatch participants. The study was conducted during the transition between the dominance of the B.1.617.2 (Delta) and B.1.1.529 (Omicron BA.1) SARS-CoV-2 variants, enabling us to investigate the association between variant-specific virus inhibition and subsequent infections within each dominance period. Greater inhibition of Omicron BA.1 live virus was associated with a reduction in infection risk during both the Delta and Omicron BA.1 dominance periods. Delta virus inhibition was associated with infection risk reduction during the Delta dominance period, but we found no association between Delta inhibition and protection against infection during the Omicron BA.1 dominance period. Our results are consistent with earlier findings and suggest that variant-specific serosurveillance of immunity and protection against SARS-CoV-2 infection at the population level could inform public health policy in near-real time using inexpensive and accessible home-based testing.

  • Open Access

    Assessing the causal effect of air pollution on risk of SARS-CoV-2 infection

    by Annalan Mathew Dwight Navaratnam, Sarah Beale, Yamina Boukari, Vincent Nguyen, Wing Lam Erica Fong, Isobel Braithwaite, Thomas E Byrne, Ellen Fragaszy, Cyril Geismar, Jana Kovar, et al.

    Introduction: Emerging evidence suggests association of air pollution exposure with risk of SARS-CoV-2 infection, but many of these findings are limited by study design, lack of individual-level covariate data or are specific to certain subpopulations. We aim to evaluate causal effects of air pollution on risk of infection, whilst overcoming these limitations. Methods: Concentrations for black carbon(BC), particulate matter 10(PM 10 ), particulate matter 2.5(PM 2.5 ), nitrogen dioxide(NO 2 ) and oxides of nitrogen(NO x ) from the Department of Environment, Food and Rural Affairs (DEFRA) and Effect of Low-level Air Pollution: A Study in Europe (ELAPSE) were linked to postcodes of 53,683 Virus Watch study participants. The primary outcome was first SARS-CoV-2 infection, between 1st September 2020 and 30th April 2021. Regression analysis used modified Poisson with robust estimates, clustered by household, adjusting for individual (e.g., age, sex, ethnicity) and environmental covariates(e.g., population density, region) to estimate total and direct effects. Results: Single pollutant analysis showed the direct effect of higher risk of SARS-CoV-2 infection with increased exposure to PM 2.5 (RR1.11,95%CI 1.08;1.15), PM 10 (RR1.06,95%CI 1.04;1.09), NO 2 (RR1.04,95%CI 1.04;1.05) and NO x (RR1.02,95%CI 1.02;1.02) per 1µg/m 3 increment with DEFRA 2015-19 data. Sensitivity analyses altering covariates, exposure window and modelled air pollution data source produced similar estimates. Higher risk of SARS-CoV-2 per 10 -5 m -1 increment of BC (RR1.86, 95%CI 1.62;2.14) was observed using ELAPSE data. Conclusion: Long term exposure to higher concentrations of air pollutions increases the risk of SARS-CoV-2 infection, highlighting that adverse health effects of air pollution is not only limited to non-communicable diseases.


  • Open Access

    Tracking Changes in Mobility Before and After the First SARS-CoV-2 Vaccination Using Global Positioning System Data in England and Wales (Virus Watch): Prospective Observational Community Cohort Study

    by Vincent Nguyen, Yunzhe Liu, Richard Mumford, Benjamin Flanagan, Parth Patel, Isobel Braithwaite, Madhumita Shrotri, Thomas Byrne, Sarah Beale, Anna Aryee, et al.

    Background: Evidence suggests that individuals may change adherence to public health policies aimed at reducing the contact, transmission, and spread of the SARS-CoV-2 virus after they receive their first SARS-CoV-2 vaccination when they are not fully vaccinated. Objective: We aimed to estimate changes in median daily travel distance of our cohort from their registered addresses before and after receiving a SARS-CoV-2 vaccine. Methods: Participants were recruited into Virus Watch starting in June 2020. Weekly surveys were sent out to participants, and vaccination status was collected from January 2021 onward. Between September 2020 and February 2021, we invited 13,120 adult Virus Watch participants to contribute toward our tracker subcohort, which uses the GPS via a smartphone app to collect data on movement. We used segmented linear regression to estimate the median daily travel distance before and after the first self-reported SARS-CoV-2 vaccine dose. Results: We analyzed the daily travel distance of 249 vaccinated adults. From 157 days prior to vaccination until the day before vaccination, the median daily travel distance was 9.05 (IQR 8.06-10.09) km. From the day of vaccination to 105 days after vaccination, the median daily travel distance was 10.08 (IQR 8.60-12.42) km. From 157 days prior to vaccination until the vaccination date, there was a daily median decrease in mobility of 40.09 m (95% CI –50.08 to –31.10; P<.001). After vaccination, there was a median daily increase in movement of 60.60 m (95% CI 20.90-100; P<.001). Restricting the analysis to the third national lockdown (January 4, 2021, to April 5, 2021), we found a median daily movement increase of 18.30 m (95% CI –19.20 to 55.80; P=.57) in the 30 days prior to vaccination and a median daily movement increase of 9.36 m (95% CI 38.6-149.00; P=.69) in the 30 days after vaccination. Conclusions: Our study demonstrates the feasibility of collecting high-volume geolocation data as part of research projects and the utility of these data for understanding public health issues. Our various analyses produced results that ranged from no change in movement after vaccination (during the third national lock down) to an increase in movement after vaccination (considering all periods, up to 105 days after vaccination), suggesting that, among Virus Watch participants, any changes in movement distances after vaccination are small. Our findings may be attributable to public health measures in place at the time such as movement restrictions and home working that applied to the Virus Watch cohort participants during the study period.


  • Open Access

    Comment: A sustainable and equitable response to the cost-of-living crisis is urgently needed

    by Claire Mulrenan, Isobel Braithwaite, Anna Brook, Rachel Crossley, Emily Loud, Angelique Mavrodaris


  • Open Access

    Cohort profile: Virus Watch: Understanding community incidence, symptom profiles, and transmission of COVID-19 in relation to population movement and behaviour

    by Thomas Byrne, Jana Kovar, Sarah Beale, Isobel Braithwaite, Ellen Fragaszy, Wing Lam Erica Fong, Cyril Geismar, Susan Hoskins, Annalan M D Navaratnam, Vincent Nguyen, et al.

    Key Features Virus Watch is a national community cohort study of COVID-19 in households in England and Wales, established in June 2020. The study aims to provide evidence on which public health approaches are most effective in reducing transmission, and investigate community incidence, symptoms, and transmission of COVID-19 in relation to population movement and behaviours. 28,527 households and 58,628 participants of age (0-98 years, mean age 48), were recruited between June 2020 - July 2022 Data collected include demographics, details on occupation, co-morbidities, medications, and infection-prevention behaviours. Households are followed up weekly with illness surveys capturing symptoms and their severity, activities in the week prior to symptom onset and any COVID-19 test results. Monthly surveys capture household finance, employment, mental health, access to healthcare, vaccination uptake, activities and contacts. Data have been linked to Hospital Episode Statistics (HES), inpatient and critical care episodes, outpatient visits, emergency care contacts, mortality, virology testing and vaccination data held by NHS Digital. Nested within Virus Watch are a serology & PCR cohort study (n=12,877) and a vaccine evaluation study (n=19,555). Study data are deposited in the Office of National Statistics (ONS) Secure Research Service (SRS). Survey data are available under restricted access upon request to ONS SRS.


  • Open Access

    The incidence of COVID-19-related hospitalisation in migrants in the UK: Findings from the Virus Watch prospective community cohort study

    by Wing Lam Erica Fong, Vincent G Nguyen, Rachel Burns, Yamina Boukari, Sarah Beale, Isobel Braithwaite, Thomas E Byrne, Cyril Geismar, Ellen Fragaszy, Susan Hoskins, et al.

    Background Migrants in the UK may be at higher risk of SARS-CoV-2 exposure; however, little is known about their risk of COVID-19-related hospitalisation during waves 1-3 of the pandemic. Methods We analysed secondary care data linked to Virus Watch study data for adults and estimated COVID-19-related hospitalisation incidence rates by migration status. To estimate the total effect of migration status on COVID-19 hospitalisation rates, we ran fixed-effect Poisson regression for wave 1 (01/03/2020-31/08/2020; wildtype), and fixed-effect negative binomial regressions for waves 2 (01/09/2020-31/05/2021; Alpha) and 3 (01/06/2020-31/11/2021; Delta). Results of all models were then meta-analysed. Results Of 30,276 adults in the analyses, 26,492 (87.5%) were UK-born and 3,784 (12.5%) were migrants. COVID-19-related hospitalisation incidence rates for UK-born and migrant individuals across waves 1-3 were 2.7 [95% CI 2.2-3.2], and 4.6 [3.1-6.7] per 1,000 person-years, respectively. Pooled incidence rate ratios across waves suggested increased rate of COVID-19-related hospitalisation in migrants compared to UK-born individuals in unadjusted 1.68 [1.08-2.60] and adjusted analyses 1.35 [0.71-2.60]. Conclusion Our findings suggest migration populations in the UK have excess risk of COVID-19-related hospitalisations and underscore the need for more equitable interventions particularly aimed at COVID-19 vaccination uptake among migrants.


  • Open Access

    SARS-CoV-2 infections in migrants and the role of household overcrowding: A causal mediation analysis of Virus Watch data

    by Yamina Boukari, Sarah Beale, Vincent Grigori Nguyen, Wing Lam Erica Fong, Rachel Burns, Alexei Yavlinsky, Susan Hoskins, Kate Marie Lewis, Cyril Geismar, Annalan M D Navaratnam, et al.

    Background Migrants are over-represented in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections globally; however, evidence is limited for migrants in England and Wales. Household overcrowding is a risk factor for SARS-CoV-2 infection, with migrants more likely to live in overcrowded households than UK-born individuals. We aimed to estimate the total effect of migration status on SARS-CoV-2 infection and to what extent household overcrowding mediated this effect. Methods We included a sub-cohort of individuals from the Virus Watch prospective cohort study during the second SARS-CoV-2 wave (1st September 2020–30th April 2021) who were aged ≥18 years, self-reported the number of rooms in their household and had no evidence of SARS-CoV-2 infection pre-September 2020. We estimated total, indirect and direct effects using Buis’ logistic decomposition regression controlling for age, sex, ethnicity, clinical vulnerability, occupation, income and whether they lived with children. Results In total, 23,478 individuals were included. 9.07% (187/2,062) of migrants had evidence of infection during the study period versus 6.27% (1,342/21,416) of UK-born individuals. Migrants had 22% higher odds of infection during the second wave (total effect; OR:1.22, 95%CI:1.01–1.47). Household overcrowding accounted for approximately 32% of these increased odds (indirect effect, OR:1.07, 95%CI:1.03–1.12; proportion accounted for: indirect effect[7]/total effect[22]=0.32). Conclusion Migrants had higher odds of SARS-CoV-2 infection during the second wave compared with UK-born individuals and household overcrowding explained 32% of these increased odds. Policy interventions to reduce household overcrowding for migrants are needed as part of efforts to tackle health inequalities during the pandemic and beyond. What is already known on this topic Migrants in England and Wales may be at greater risk of exposure to SARS-CoV-2 due to unique risk factors, including over-representation in front-line jobs, an increased likelihood of living in multigenerational households and difficulties in accessing primary care. Research shows that migrants in high-income countries have been disproportionally infected with SARS-CoV-2. It is likely that, due to their pre-existing vulnerabilities, this is similarly the case for migrants in England and Wales; however, quantitative evidence addressing this is lacking. What this study adds We investigated the effect of being a migrant on SARS-CoV-2 infection during the second wave of the pandemic in a cohort in England and Wales. We also determined the proportion of the effect mediated by household overcrowding after controlling for age, sex, ethnicity, clinical vulnerability, occupation, income and the presence of children in the household. Migrants had 22% higher odds of being infected with SARS-CoV-2 than their UK-born counterparts, and household overcrowding accounted for approximately 32% of these increased odds. How this study might affect research, practice or policy Our findings highlight the role of household overcrowding in the disproportionate impact of SARS-CoV-2 infections on migrants. They also demonstrate the urgent need for policy interventions that improve housing conditions as part of efforts to reduce health inequalities. Further research investigating other causes of migrants’ over-representation in infection cases is also needed to inform further targeted policy interventions.